Related Experiment Video
Updated: May 9, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Childhood myelodysplastic syndrome.
Tathagata Chatterjee1, V P Choudhry
1Department of Immunohematology and Transfusion Medicine, AFMC, Pune 411040, India. ctathagat@hotmail.com
Indian Journal of Pediatrics
|August 6, 2013
Summary
Childhood myelodysplastic syndrome (MDS) is rare, with refractory cytopenia of childhood being most common. Hematopoietic stem cell transplantation offers the best cure, especially for those with specific genetic defects like monosomy 7.
Area of Science:
- Pediatric Hematology
- Oncology
- Bone Marrow Disorders
Background:
- Myelodysplastic syndrome (MDS) is a rare bone marrow disorder in children, characterized by ineffective blood cell production and risk of leukemia.
- Childhood MDS is diverse, including de novo, secondary, and therapy-related forms, with Down syndrome-associated MDS being a distinct entity.
- Refractory cytopenia of childhood (RCC) is the most frequent subtype of pediatric MDS.
Purpose of the Study:
- To summarize the key characteristics of childhood myelodysplastic syndrome.
- To highlight the genetic factors and common cytogenetic abnormalities in pediatric MDS.
- To discuss the primary treatment options and their efficacy.
Main Methods:
- Review of existing literature on childhood myelodysplastic syndrome.
- Analysis of reported cases regarding clinical presentation, genetics, and treatment outcomes.
- Synthesis of information on diagnostic criteria and prognostic factors.
Main Results:
- Monosomy 7 is the most common cytogenetic abnormality in childhood MDS, though many cases have a normal karyotype.
- Down syndrome-associated MDS is biologically unique and accounts for a significant proportion of pediatric cases.
- Refractory cytopenia of childhood (RCC) represents the most prevalent form of MDS in children.
Conclusions:
- Hematopoietic stem cell transplantation is the most effective curative treatment for childhood MDS.
- Early intervention with stem cell transplantation is crucial for favorable outcomes, particularly in patients with monosomy 7 or complex karyotypes.
- Further research is needed to elucidate the genetic underpinnings of childhood MDS, especially in cases with normal karyotypes.
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...